We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLR icon
2551
Miller Industries
MLR
$640M
$47K ﹤0.01%
1,338
+547
+69% +$16.2K
OXM icon
2552
Oxford Industries
OXM
$542M
$47K ﹤0.01%
438
-1,920
-81% -$215K
PCRX icon
2553
Pacira BioSciences
PCRX
$924M
$47K ﹤0.01%
1,153
-825
-42% -$32.8K
PLUS icon
2554
ePlus
PLUS
$2.31B
$47K ﹤0.01%
957
-5,365
-85% -$272K
TAK icon
2555
Takeda Pharmaceutical
TAK
$55.5B
$47K ﹤0.01%
2,836
+527
+23% +$8.39K
TECK icon
2556
Teck Resources
TECK
$31.3B
$47K ﹤0.01%
1,278
-3,120
-71% -$124K
VEA icon
2557
Vanguard FTSE Developed Markets ETF
VEA
$239B
$47K ﹤0.01%
1,044
-4,696
-82% -$209K
IMGN
2558
DELISTED
Immunogen Inc
IMGN
$47K ﹤0.01%
12,208
-35,849
-75% -$153K
AVUV icon
2559
Avantis US Small Cap Value ETF
AVUV
$31B
$46K ﹤0.01%
+627
New +$49.1K
CCAP icon
2560
Crescent Capital BDC
CCAP
$417M
$46K ﹤0.01%
3,391
+2,704
+394% +$39.2K
CIM
2561
Chimera Investment
CIM
$993M
$46K ﹤0.01%
2,664
-188
-7% -$3.6K
CTRE icon
2562
CareTrust REIT
CTRE
$9.18B
$46K ﹤0.01%
2,344
+1,841
+366% +$36K
ENTA icon
2563
Enanta Pharmaceuticals
ENTA
$391M
$46K ﹤0.01%
1,125
+790
+236% +$37.7K
GERN icon
2564
Geron
GERN
$982M
$46K ﹤0.01%
21,075
-13,933
-40% -$39.6K
GRC icon
2565
Gorman-Rupp
GRC
$2.11B
$46K ﹤0.01%
1,838
+445
+32% +$11.9K
GSK icon
2566
GSK
GSK
$101B
$46K ﹤0.01%
1,285
-1,710
-57% -$59.8K
HAIN icon
2567
Hain Celestial
HAIN
$53.9M
$46K ﹤0.01%
2,690
+2,120
+372% +$38.6K
JRVR icon
2568
James River Group Holdings
JRVR
$200M
$46K ﹤0.01%
2,236
+1,998
+839% +$44K
KW
2569
DELISTED
Kennedy-Wilson Holdings
KW
$46K ﹤0.01%
2,765
+2,015
+269% +$34.3K
MWA icon
2570
Mueller Water Products
MWA
$3.98B
$46K ﹤0.01%
3,291
+1,873
+132% +$24.4K
NVMI
2571
Nova
NVMI
$13.1B
$46K ﹤0.01%
442
-2,333
-84% -$218K
PFBC icon
2572
Preferred Bank
PFBC
$1.28B
$46K ﹤0.01%
823
-185
-18% -$12.5K
POWW icon
2573
Outdoor Holding Co
POWW
$255M
$46K ﹤0.01%
23,571
-15,451
-40% -$31.9K
RETL icon
2574
Direxion Daily Retail Bull 3X ETF
RETL
$27.8M
$46K ﹤0.01%
6,193
-66,059
-91% -$571K
TBLA icon
2575
Taboola.com
TBLA
$1.06B
$46K ﹤0.01%
16,823
+16,462
+4,560% +$55.5K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.